• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Thomas K. Thomas

New Delhi, Sept. 25 Ranbaxy Laboratories Ltd’s woes continued with New Zealand’s health ministry saying that three drugs imported into that country will be voluntarily quarantined by the suppliers till further tests are done. These three drugs are part of the 30 medicines blocked by the United States Food and Drug Administration on the grounds that the Ranbaxy had failed to meet manufacturing standards in two of its plants in India.

“The two suppliers of the three Ranbaxy funded products available in New Zealand, Douglas Pharmaceuticals Ltd and Apotex New Zealand Ltd, have agreed to voluntarily hold the products, which are due in the country in October. This means the products will be held in quarantine at the companies’ own warehouses, and not released for distribution,” said a statement from the New Zealand Health Ministry.

Meanwhile, in another blow, AIDS drugs made by Ranbaxy will not be purchased under an American programme to supply medicines to developing countries.

More Stories on : Pharmaceuticals | Standards & Benchmarks | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line